Adverse Event Reports Hit All-Time High; FDA Warns Firms About MDRs, Complaint Handling
This article was originally published in The Silver Sheet
Executive Summary
As FDA sifts through almost a million Medical Device Reports submitted by manufacturers last year, the agency is trying to determine why so many adverse events are being reported. Isaac Chang, a director in CDRH’s Office of Surveillance and Biometrics, speculates that there could be a number of reasons for the large influx of MDRs, including high-profile recalls and a sharper FDA focus on human factors issues. Further, more than half of adverse events were reported to the agency on individual MedWatch forms in 2012 – a sharp increase over previous years. However, despite the extraordinary rise in reports, some firms continue to have trouble developing MDR procedures. Industry experts also weigh in on social media’s impact on adverse event reporting, and tips are shared for ensuring that complaints are properly handled by manufacturers.
You may also be interested in...
News In Brief
FDA finally releases rule requiring electronic Medical Device Reporting; eReporting initiative for recalls struggles; and more.
Year In Review: Complaint Handling, UDI, FDA Inspections, And More
The top quality-related topics manufacturers faced last year included a new FDA regulation to track and trace devices, innovative supply chain initiatives and an update to the agency’s Medical Device Reporting guidance, among others. Plus honorable mentions: product recalls, human factors and FDA compliance meetings.
Experts: MDR Draft Guidance Compiles Advice, Seeks More Info From Firms
While much of the information found in FDA’s new 47-page draft guidance for Medical Device Reporting can be found in the MDR regulation, it nevertheless compiles a wealth of advice that the agency has doled out over a number of years.